Metabolic outcome during 1 year in newly detected hypertensives
- 1 August 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 21 (8), 1563-1574
- https://doi.org/10.1097/00004872-200308000-00022
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Antihypertensive Treatment with Candesartan Cilexetil does not Affect Glucose Homeostasis or Serum Lipid Profile in Patients with Mild Hypertension and Type II DiabetesBlood Pressure, 1998
- Metabolic manifestations of low-dose diureticsAmerican Journal Of Medicine, 1996
- Glucose and cholesterol elevations during thiazide therapy: Intention-to-treat versus actual on-therapy experienceAmerican Journal Of Medicine, 1995
- Inflammatory bowel disease: genes or germs?Journal of Internal Medicine, 1995
- Clinical review 43: Treatment of hypertension: focus on prevention of coronary heart diseaseJournal of Clinical Endocrinology & Metabolism, 1993
- Effects on Plasma Lipids during Long Term Antihypertensive Treatment with FelodipineClinical Drug Investigation, 1992
- Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid MetabolismDiabetes Care, 1991
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextThe Lancet, 1990
- Antihypertensive therapy and lipids: Paradoxical influences on cardiovascular disease riskAmerican Journal Of Medicine, 1986